Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sandler

Showing results (651-660 of 870) with videos related to

Pageof 87
Sort By:
Clinical Endocrinology|May 1, 1982
Control of secretion of parathyroid hormone in secondary hyperparathyroidismS Adami, N Muirhead, R M Manning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancerJohn T Wei, Rodney L Dunn, Howard M Sandler, et al.
CA: a Cancer Journal for Clinicians|February 22, 2017
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manualMark K Buyyounouski, Peter L Choyke, Jesse K McKenney, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 1992
The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasmsA F Thornton, H M Sandler, R K Ten Haken, et al.
Journal of Ovarian Research|September 21, 2017
Activated ovarian endothelial cells promote early follicular development and survivalAlon Kedem, Anate Aelion-Brauer, Peipei Guo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablationAaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Journal of the National Cancer Institute|July 2, 1997
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory studyK A Cooney, J D McCarthy, E Lange, et al.
Urology|March 1, 2008
Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancerDaniel E Soto, Scott Glaser, Rebecca H Roberts, et al.
Urology|July 18, 2006
Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifferenceDavid C Miller, John T Wei, Rodney L Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10Rile Li, Kateri Heydon, M Elizabeth Hammond, et al.
Pageof 87

Showing results (651-660 of 870) with videos related to

Sort By:
Pageof 87
Clinical Endocrinology|May 1, 1982
Control of secretion of parathyroid hormone in secondary hyperparathyroidismS Adami, N Muirhead, R M Manning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancerJohn T Wei, Rodney L Dunn, Howard M Sandler, et al.
CA: a Cancer Journal for Clinicians|February 22, 2017
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manualMark K Buyyounouski, Peter L Choyke, Jesse K McKenney, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 1992
The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasmsA F Thornton, H M Sandler, R K Ten Haken, et al.
Journal of Ovarian Research|September 21, 2017
Activated ovarian endothelial cells promote early follicular development and survivalAlon Kedem, Anate Aelion-Brauer, Peipei Guo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablationAaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Journal of the National Cancer Institute|July 2, 1997
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory studyK A Cooney, J D McCarthy, E Lange, et al.
Urology|March 1, 2008
Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancerDaniel E Soto, Scott Glaser, Rebecca H Roberts, et al.
Urology|July 18, 2006
Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifferenceDavid C Miller, John T Wei, Rodney L Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10Rile Li, Kateri Heydon, M Elizabeth Hammond, et al.
Pageof 87